Estudio de vericiguat en participantes con insuficiencia cardíaca crónica con fracción de eyección reducida
The purpose of this study is to evaluate the efficacy and safety of vericiguat in participants with chronic heart failure with reduced ejection fraction (HFrEF), specifically those with symptomatic chronic HFrEF